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ABSTRACT
MicroRNAs (miRNAs), a class of post-transcriptional
gene expression regulators, have recently been
detected in human body fluids, including peripheral
blood plasma as extracellular nuclease resistant
entities. However, the origin and function of extra-
cellular circulating miRNA remain essentially un-
known. Here, we confirmed that circulating mature
miRNA in contrast to mRNA or snRNA is strikingly
stable in blood plasma and cell culture media.
Furthermore, we found that most miRNA in plasma
and cell culture media completely passed through
0.22mm filters but remained in the supernatant
after ultracentrifugation at 110000g indicating the
non-vesicular origin of the extracellular miRNA.
Furthermore, western blot immunoassay revealed
that extracellular miRNA ultrafiltrated together with
the 96kDa Ago2 protein, a part of RNA-induced
silencing complex. Moreover, miRNAs in both
blood plasma and cell culture media co-immunopre-
cipited with anti-Ago2 antibody in a detergent free
environment. This is the first study to show that
extracellular miRNAs are predominantly exosomes/
microvesicles free and are associated with Ago
proteins. We hypothesize that extracellular
miRNAs are in the most part by-products of dead
cells that remain in extracellular space due to the
high stability of the Ago2 protein and Ago2-miRNA
complex. Nevertheless, our data does not reject the
possibility that some miRNAs can be associated
with exosomes.
INTRODUCTION
MicroRNAs (miRNAs) are a class of 19–23nt long
non-coding RNAs that negatively regulate the expression
of mRNAs containing respective miRNAs target se-
quences (1). MiRNAs have been shown to regulate
genes involved in differentiation, proliferation, apoptosis
and to be implicated in several diseases including cancer
(2,3). Recently, signiﬁcant amounts of miRNA have been
found in extracellular human body ﬂuids including blood
plasma, urine, saliva and semen (4–7). Moreover, some
circulating miRNAs in the blood have been successfully
revealed as biomarkers for several cancers, cardiovascular
disease, brain injury and liver injury (4,8–11). Mammalian
cells in culture have been also reported to export miRNAs
into the extracellular environment (12–15); however,
the mechanism of origin and the function of extracellular
miRNA remain essentially unclear. Extracellular miRNAs
have recently been detected in exosomes isolated from per-
ipheral blood and culture media of several cell lines
(12,16). Although, exosomal miRNA has been hypothe-
sized to be involved in intercellular communication (12,15)
it remains unclear whether all extracellular miRNAs are
associated with exosomes and whether extracellular
miRNA are present in physiologically relevant amounts
for cell-to-cell signaling. Another study has indicated that
cells in culture predominantly exported miRNA in
exosome-independent form (13).
In this study, we show that most of the extracellular
miRNA in blood plasma and cell culture is independent
from exosomes and is bound to Ago2 protein—a part of
RNA-induced silencing complex. Further, we found some
indications that also other Ago proteins such as Ago1,
Ago3 and Ago4 might be associated with extracellular
miRNA. This and further presented results indicate that
large parts of circulating miRNAs might be by-products
of dead/dying cells which persist due to the stability of the
miRNA/Ago2 complex. If and to what extent miRNA/
Ago2 complexes can be purposively released from cells
and act in paracrine manner remain to be investigated.
MATERIALS AND METHODS
Cell culture
All cells were obtained from the American Type Culture
Collection (ATCC). Human HEK293T, MCF7 and
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Eagle’s medium (DMEM) (Invitrogen, cat. 11960-044)
supplemented with 10% heat-inactivated fetal bovine
serum (FBS), 4mM L-Glutamine and penicillin/strepto-
mycin at 37Ci n5 %C O 2. Human T47D and HCC1954
cells were grown in RPMI supplemented with 10% FBS,
1% non-essential amino acids and penicillin/streptomycin
at 37Ci n5 %C O 2. For RNA isolation, cells were plated
at a density of 10
5 cells per well in a 24-well plate, the
media was renewed 12h after plating and the total
RNA isolated 3 days after plating (along with the collec-
tion of conditioned media). For overexpression of
hsa-miR-34b, MCF7 cells were transfected with 400ng
(per well) of plasmid DNA encoding pri-miR-34b
(System Biosciences, cat. PMIRH34B PA-1) using
Turbofect transfection reagent (Fermentas) according to
the manufacturer’s protocol. For the overexpression of
Ago proteins HEK293T cells were transiently transfected
with pIRESneo-FLAF-HA-Ago1, pIRESneo-FLAF-HA-
Ago2, pIRESneo-FLAF-HA-Ago3 and pIRESneo-
FLAF-HA-Ago4 using Turbofect transfection reagent
(Fermentas) according to the manufacturer’s protocol.
Next day after transfection the media was renewed.
Conditioned media was collected 72h post-transfection,
concentrated 10 times using Vivaspin2 10kDa MWCO
columns (Sartorius Stedim GmbH, Heidelberg,
Germany) and used in co-immunoprecipitation
experiments.
Collection of human blood and plasma preparation
EDTA-Blood was collected from healthy donors and pro-
cessed for plasma isolation immediately after collection.
Blood plasma was centrifuged at 14000g for 10min and
diluted 1/10 in 1PBS (w/o Ca, Mg) before ﬁltration
through 0.22mm ﬁlters (MillexGS, Millipore),
ulftraﬁltration, ultracentrifugation and RNA isolation.
This study has been approved by the ethics committee,
Heidelberg, Germany.
Preparation of conditioned media, ultracentrifugation and
ultraﬁltration
To obtain conditioned media for RNA isolation, ultracen-
trifugation and ultraﬁltration, MCF7 cells were seeded in
culture ﬂasks and the media was renewed 12h after
plating. After 3 days in culture, media were collected
and centrifuged at 1200g for 3min at RT to remove
living cells and subsequently centrifuged at 14000g for
10min at RT to remove cell debris. For the ultracentrifu-
gation, 6ml of conditioned media were combined with
6ml of DMEM and the resulting 12ml were loaded into
the ultracentrifugation tube. Ultracentrifugation of blood
plasma (diluted 1/10 in PBS) and conditioned media was
performed at 110000g for 2h at 4C. The 110000 g pellets
were washed twice with 1PBS and then dissolved in
700ml of Qiazol reagent for total RNA isolation
(Qiagen). Ultraﬁltration of blood plasma (diluted 1/10 in
PBS) and conditioned media was performed using
Vivaspin20 columns (Sartorius Stedim GmbH) with 300,
100 and 50kDa MWCO according to the manufacturer’s
instructions.
Isolation of miRNAs
Isolation of extracellular miRNAs from liquid samples
was performed using Tri-Reagent LS (Sigma) together
with miRNeasy kit (Qiagen). Brieﬂy, 1.2ml of Tri-
Reagent LS were added to 0.4ml of blood plasma or con-
ditioned media, mixed by vigorous shaking for 10s and
then incubated for 10min at RT to ensure complete dis-
sociation of nucleoprotein complexes. Then (i) 5pg of syn-
thetic miRNA-39 from Caenorhabditis elegans
(cel-miRNA-39) were added as a spike-in control for puri-
ﬁcation efﬁciency; (ii) 1.2ml of glycogen (10mg/ml) were
added to enhance the efﬁciency of RNA column binding.
After supplying 320ml of chloroform, the mixture was vig-
orously shaken for 45s and allowed to stand for 5min at
RT. Following the centrifugation at 14 000g for 20min
total RNA was precipitated from the upper (aqueous)
phase by adding 1.5 V of 100% ethanol. Puriﬁcation of
extracted total RNA was performed with miRNeasy
columns (Qiagen) according to the manufacturer’s instruc-
tions. From the Qiagen columns, RNA was eluted in 30ml
of RNase-free water. Total RNA from cells monolayers
grown on 24-well plates was isolated using Qiazol reagent
(Qiagen) in combination with miRNAeasy kit (Qiagen)
according to the manufacturer’s protocol. To monitor
the extraction efﬁcacy, 5pg of cel-miR-39 was added to
the cell/Qiazol lysates. RNA was eluted in 30mlo f
RNase-free water.
Quantitative real-time PCR
A ﬁxed volume of 5ml of total RNA from 30ml eluates
obtained after RNA isolation of a given sample was used
as an input into a reverse transcription (RT) reaction. The
levels of a-tubulin and b-actin mRNAs were measured
using corresponding TaqMan Gene Expression Assays
(Applied Biosystems) according to the manufacturer’s in-
structions. The levels of mature hsa-miR-16, hsa-miR-21,
hsa-miR-24, hsa-miR-34b, cel-miR-39 mRNAs were
measured using individual TaqMan microRNA Assays
(Applied Biosystems) according to the manufacturer’s in-
structions with minor modiﬁcations. Cel-miR-39 was used
for the normalization of both extracellular and intracellu-
lar miRNAs levels. Since we compared intracellular and
extracellular expression of miRNAs in the same cell line it
was possible to use only cel-mir-39 as spiked-in control for
the normalization of miRNAs in the cells as well as in the
media. Reverse transcriptase reactions contained 5mlo f
puriﬁed total RNA, 50/NnM stem–loop RT primers
(where N is a number of analysed miRNAs), 1RT
buffer, 0.25mM each of dNTPs, 3.33U/ml MultiScribe
reverse transcriptase and 0.25U/ml RNase inhibitor. RT
reaction had ﬁnal volume of 15ml were incubated for
30min at 16C, 30min at 42C, 5min at 85C and then
held at 4C. RT product was further diluted six times with
RNAse-free water. Real-time PCR was performed using
Taqman Universal PCR Master Mix. A 10ml PCR
reaction included 2ml of diluted RT product,
1TaqMan Universal PCR Master Mix (Applied
Biosystems) and 1of the corresponding miRNA assay
primers. The reactions were incubated in 384-well plates
at 95C for 10min, followed by 50 cycles of 95C for 15s
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Real-time PCR was performed using the LightCycler 480
Real-Time PCR System (Roche). Data was analyzed with
the LightCycler 480 software (Roche), determining the
threshold cycle (Ct) by the second derivative max
method. Relative quantities of miRNA were calculated
using the Ct method after normalization to the
cel-miR-39 spiked-in control.
miRNA proﬁling
The expression of miRNA in the blood plasma, MCF7
cells, MCF7 cells conditioned media, control DMEM+
10% FBS and 110000 g pellets was proﬁled using stem–
loop RT–PCR-based TaqMan Human MicroRNA
Arrays (Applied Biosystems). The arrays represented 667
mature miRNAs and miRNAs* present in the Sanger
miRBase v12 in a two-card set of arrays (Array A v2.1
and Array B v2.0). RT-PCR reactions were performed
according to the manufacturer’s instructions. Brieﬂy,
total RNA (3ml per reaction) was reverse transcribed
using TaqMan miRNA Reverse Transcription Kit
(Applied Biosystems) in combination with the stem–loop
Megaplex primers pool sets A and B in total volume of
7.5ml. The RT cycling conditions were: 40 cycles of 16C
for 2min, 42C for 1min and 50C for 1s. Megaplex RT
products were further pre-ampliﬁed using TaqMan
PreAmp Master Mix and Megaplex PreAmp primers
(Applied Biosystems). Brieﬂy, 2.5ml of the megaplex RT
products were mixed with 2.5ml of Megaplex PreAmp
Primers (pool A or B) and 12.5ml TaqMan PreAmp
Master Mix in a 25ml PCR reaction. The pre-ampliﬁcation
cycling conditions were 95C for 10min, 55C for 2min
and 75C for 2min followed by 12 cycles of 95C for 15s
and 60C for 4min. The pre-ampliﬁed cDNA was diluted
with 0.1 TE (pH 8.0) to 100ml and 10ml of diluted
cDNA was used in each plate for real-time PCR reactions.
The expression proﬁles of miRNA were acquired using
TaqMan Low-Density Arrays. Brieﬂy, quantitative
real-time PCR was carried out on Applied BioSystems
7900HT thermocycler using the manufacturer’s recom-
mended cycling conditions. Cycle threshold (Ct) values
were calculated with the SDS software v2.3 using auto-
matic baseline settings with assigned minimum threshold
of 0.2. Because of the fact that the Ct value of 35 repre-
sents single template detection, Ct value >35 were con-
sidered to be below the detection level of the assays (17).
Therefore, all miRNAs with Ct>35 were included in the
analysis as ‘undetected’ and assigned the Ct values of 40.
Array experiments were performed only once using
samples from one biological experiment. Those miRNAs
that appeared on the DMEM+10% FBS (negative control
sample) array were removed from the analysis (for all
miRNAs that were more than 1.5  Ct, as compared to
conditioned media samples).
Immunoprecipitation
Immunoprecipitation of extracellular miRNAs with anti-
Ago2 antibody (Abnova, clone 2E12-1C9; cat.
H00027161-M01) was performed using Pierce Classic IP
kit (Thermo Scientiﬁc). Binding with anti-Ago2 was
carried out in a detergent-free solution. The maximal efﬁ-
ciency of immunoprecipitation was achieved when 5mgo f
anti-Ago2 antibody was combined with 5ml of sample.
Brieﬂy, 10mlo f1 PBS were added to 5mlo f2 
concentrated human blood plasma (or 10 concentrated
conditioned media) to form 15ml of miRNA binding
solution. The concentration of the samples was performed
using Vivaspin2 columns with 10kDa MWCO (Sartorius
Stedim GmbH). To form Ago2/anti-Ago2 complexes,
15ml of corresponding miRNA binding solutions were
combined with 5mg (10ml) of anti-Ago2 antibody and
incubated overnight at +4C. To capture the immune
complexes, 20ml Pierce Protein A/G Agarose suspended
in 200mlo f1 PBS was added to the antibody/lysate
samples and incubated for 2h on a shaker at RT. The
A/G Agarose resin was washed two times with 1ml of
IP Lysis/Wash buffer. Afterwards, 700ml of Qiazol
reagent was added to the resin and total RNA was
isolated with the miRNeasy kit (Qiagen) as described
above. Cel-miR-39 (5pg) was spiked into the samples
after addition of Qiazol reagent and used as normalization
control. Immunoprecipitation of exogenously expressed
FLAG-fused Ago proteins was approached similarly,
except that 100mlo f1 0  concentrated conditioned
media was combined with 200ml of Pierce IP Lysis
buffer (0.025 M Tris, 0.15 M NaCl, 0.001 EDTA, 1%
NP-40, 5% glycerol, pH 7.4) before incubating with
10mg of mouse anti-FLAG antibody (Sigma, clone M2).
Western blot analysis
Retinates or pellets collected after ultraﬁltration or ultra-
centrifugation, respectively, were dissolved in 100mlo f
Laemmli loading buffer (250mM Tris–HCl pH 6.4; 2%
SDS; 100nM b-MeEtOH), separated by 8% or 12%
SDS-PAGE and transferred to nitrocellulose membranes
(Amersham Pharmacia, Freiburg, Germany). Membranes
were blocked with 5% non-fat milk powder (Roche,
Mannheim, Germany) in 1TBS containing 0.1%
Tween-20. Incubation with primary monoclonal mouse
anti-Ago2 antibodies (Abnova, clone 2E12-1C9; cat.
H00027161-M01), rabbit polyclonal anti-NPM1 (Sigma,
clone AB1) or mouse anti-CD9 (R&D systems GmbH)
was performed at 4C overnight in a 1:1000 dilution.
After incubation with the primary antibody, membranes
were washed twice in 1TBS with 0.1% Tween-20 for
10min and incubated for 1h at room temperature with
horseradish peroxidase (HRP) conjugated goat anti-
mouse IgG (Santa Cruz, sc-2005) or goat anti-rabbit
IgG (Santa Cruz, sc-2004) diluted (1:10000) in blocking
solution. Membranes were washed four times for 10min in
TBS–Tween20 and ﬁnally developed with Pierce ECL
Western Blotting Substrate (Thermo Scientiﬁc) according
to the instructions of the manufacturer.
RESULTS
Extracellular versus intracellular miRNA expression
pattern
We ﬁrst conﬁrmed the presence of the nuclease-resistant
miRNA species in an extracellular environment. For that
Nucleic Acids Research, 2011,Vol.39, No. 16 7225purpose, total RNA was isolated from the conditioned
media of MCF7 cells and subjected to TaqMan quantita-
tive real-time PCR (qRT–PCR) mature miRNA assays
(Applied Biosystems) using pre-designed primers. Species
of hsa-miR-16, hsa-miR-21 and hsa-miR-24 as well as
a-tubulin and b-actin mRNAs were detected as described
in ‘Materials and Methods’ section (Figure 1A).
Centrifugation of the cell-free conditioned media at
14000g for 10min and subsequent ﬁltration through
0.22mm ﬁlters did not decrease the concentration of extra-
cellular miRNAs in the samples. This indicated that these
miRNAs species were neither associated with cells debris
nor micro-vesicles. Extracellular miRNAs were resistant
to nuclease degradation as synthetic cel-miR-39 was im-
mediately degraded when spiked into the media 1min
before the addition of denaturing Tri-Reagent LS
(Figure 1A). Furthermore, incubation of conditioned
media with 100ng/ml of RNAseA for 15min did not
affect the levels of endogenous miRNAs (Figure 1A). On
the contrary, no a-tubulin mRNA and only trace amounts
of b-actin mRNA was detected in the conditioned media.
We further investigated if cells in culture secreted
miRNA speciﬁcally. For that purpose we compared extra-
cellular and intracellular levels of hsa-miR-16, hsa-miR-21
and hsa-miR-24 species in several breast cancer cell lines
(Figure 1B). Interestingly, bovine miRNAs were detected
in DMEM medium supplemented with 10% bovine
serum, furthermore indicating enormous stability of the
extracellular miRNAs. However, in the conditioned
media (following incubation with the cells) the analyzed
miRNAs were present in signiﬁcantly higher amounts
(several magnitudes) than in DMEM+ 10% bovine
serum alone (Figure 1B). Therefore, the presence of
bovine miRNA had no substantial effect on the analysis.
We further observed that in all cell lines intracellular and
extracellular patterns of miRNA-16 and miRNA-24 were
well correlated (Figure 1B). Overexpression of randomly
selected miRNA-27a with pri-miR-27a encoding plasmid
in both HEK293 and MCF7 cells led to the proportional
increase of miRNA-27a level in the conditioned media
(data not shown), so favoring the hypothesis of
non-speciﬁc export of miRNAs. However, in all cell
lines analyzed, the amount of miRNAs exported into the
media over 3-day period was dramatically lower as
compared to the miRNAs amount in the monolayers of
the parental cells (Figure 1B). The mean Ct values of
extracellular to intracellular miRNAs signals in ﬁve
analyzed cell lines were as follows: 8.5±0.84 for
miR-16; 6.6±0.78 for miR-21; 8.8±1.08 for miR-24.
Surprisingly, higher concentration of miR-21 in the
media was found as compared to extracellular miR-16
and miR-24, indicating that intracellular and extracellular
miRNA levels were not parallel for all miRNAs. The
observed difference between extracellular/intracellular
levels of miRNA-21 and miR-16/miR-24 cannot be
attributed to the difference in primers’ efﬁcacy as they
were near equal for these miRNA species (data not
shown). Second, we evaluated miRNA expression proﬁle
of MCF7 breast cancer cells versus miRNA content in
their media. Considering miRNAs with Ct values of <35
as ‘detected’ 150 miRNA species were exclusively detected
in the cells monolayers while 168 miRNAs were detected
both in the cells and in the media (Figure 1C). Only three
miRNA species were found exclusively in the media
(Figure 1C, EM; Supplementary Table S1). However,
the Ct values of these miRNAs ranged from 32.6 to 33.8
and were, therefore, close to the undetectable levels. The
proﬁles of extracellular and intracellular miRNAs (for
miRNAs detected in both cells and media) were strongly
correlated (Figure 1C and D). The average Ct of cellular
to extracellular miRNAs was 7.5 indicating that the
amount of miRNA was approximately 180 times higher
in the cell monolayers than in 3-day conditioned media.
Small RNA species of non-miRNA origin including U6,
RNU24, RNU48, RNU6B, RNU43 and RNU44 were
presented in high amounts (Ct 12.9–24.8) within the cells
but were either totally absent (RNU43, RNU44, RNU6B)
or had signiﬁcantly lower Ct values (Ct>12) in the
media (Table 1). On the whole-miRNA proﬁle level, we
did not perform any quantitative calculations of extracel-
lular to intracellular miRNA amounts but merely aimed
to qualitatively demonstrate that: (i) none of the miRNAs
was present in higher concentrations outside the cells and
(ii) the extracellular proﬁle of miRNAs closely but not
completely relates to the intracellular miRNA expression
pattern.
Most of the extracellular miRNAs are not associated with
exosomes
Extracellular miRNAs have been previously detected in
cell-exported exosomes, small membrane vesicles of 50–
100nm in diameter (12,14–16). However, to our know-
ledge, no experiments demonstrating that extracellular
miRNA is associated exclusively with exosomes have
been described. We have noticed that incubation of
either blood plasma or conditioned media with the 1%
NP-40 detergent did not restore the nuclease sensitivity
of extracellular miRNAs (data not shown). To further
conﬁrm the hypothesis of exosome-free extracellular
miRNA, we fractionated blood plasma and conditioned
media of MCF7 cells according to well-developed
methods for exosomes isolation (12,18). Thus, cell debris
and microvesicles were removed from the samples by ﬁl-
tration through 0.22mm ﬁlters; the exosome-free fractions
were obtained by further ultracentrifuging the samples at
110000g for 2h at+4C (Figure 2A and B). The levels of
three miRNA species (hsa-miR-16, hsa-miR-21 and
hsa-miR-24) were quantitatively assayed in the samples
after each fractionation step with individual TaqMan
miRNA Assays. To our surprise, ultracentrifugation did
not signiﬁcantly decrease the level of any of these miRNAs
in both blood plasma and conditioned media (Figure 2C
and D). Accordingly, 110000g pellets contained only trace
amounts of the respective miRNAs (blood plasma:
miR-16: 0.34±0.07%; miRNA-21: 0.21±0.14%;
miRNA-24: 0.94±0.68%; MCF7 media: miR-16:
1.57±0.5%; miRNA-21: 1.9±1.18%; miRNA-24:
1.19±0.80%). The presence of exosomal marker
protein CD9 in 110 000g pellets was conﬁrmed by
western immunoblot analysis (Figure 2B). Furthermore,
TaqMan Low Density Array (Applied Biosystems) of
7226 Nucleic Acids Research, 2011,Vol.39, No. 16707 different miRNAs and miRNAs* performed on total
RNAs isolated from 400ml (1/30V) of 110000g super-
natants and total 110000g pellets revealed that only a
small proportion of all miRNAs was speciﬁcally
associated with the pellet fractions in both plasma and
conditioned media (Figure 3). Those miRNAs that
appeared on the proﬁle with Ct value of <35 were con-
sidered as ‘detected’. In the conditioned media the average
Ct of miRNAs detected in 1/30V supernatant and
1V pellet was 1.6 indicating 90 times higher miRNA
amounts in the supernatant compared to pellet
(Figure 3A). Extracellular miRNAs that were found ex-
clusively in the exosomes-free supernatant and in the
exosomes-containing pellet are listed in Supplementary
Tables S2 and S3. Out of 188 miRNA species detected
in the blood plasma, 97 miRNAs were detected both in
the pellet and supernatant (Figure 3B) and 69 miRNA
species were found exclusively in the supernatant
(Figure 3B, ES; Supplementary Table S4). Only 22 differ-
ent miRNAs were detected exclusively in the pellet
fraction of blood plasma (Figure 3B, EP; Supplementary
Table S5), however, the Ct values of these miRNAs ranged
from 30.8 to 34.9. The average Ct for miRNAs between
1/30 V supernatant and 1 V pellet was 1.4 indicating that
the amount of miRNA was 80 times higher in the
plasma supernatant compared to the pellet. Therefore,
our data strongly indicates that the level of miRNAs
that can be associated with exosomes is dramatically lower
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volume of blood plasma or conditioned media.
Extracellular miRNA is associated with Ago2 protein
We further hypothesized that exosome-free extracellular
miRNA could be protected from nuclease digestion by
associated proteins. To estimate the approximate molecu-
lar weight of ‘extracellular miRNA binding protein’, we
applied a sequential ultraﬁltration procedure (Figure 2A
and B). For this purpose 0.22mm ﬁltered blood plasma
and conditioned media were further fractionated by cen-
trifugal ultraﬁltration using nanomembrane concentrators
of 300, 100 and 50kDa MWCO. Individual TaqMan
miRNA Assays were used to quantify the species of
hsa-miR-16, hsa-miR-21 and hsa-miR-24 which
remained in the samples after each ultraﬁltration step. In
conditioned media, extracellular miRNA completely
passed through 300kDa MWCO ﬁlters, 50% of the
investigated miRNAs passed through 100kDa MWCO
ﬁlter and only a negligible amount of miRNAs were
found in the 50kDa ﬁltrate (Figure 2C). The fact that
300kDa MWCO nanomembranes were permeable for
extracellular miRNAs provided an additional evidence
of exosome-free presence of extracellular miRNA.
Similarly to the conditioned media, most of the miRNA
was still found in the 300kDa ﬁltrates in blood plasma
(Figure 2D). However, roughly 90% of miRNA did not
pass through 100kDa ﬁlters and 50kDa ﬁltrates were
almost totally depleted of miRNAs (Figure 2D). When
serum-free 1-day conditioned media from MCF7 cells
was sequentially fractionated, the percent of miRNA
that passed through 100kDa MWCO nanomembranes
was about 70% while near 5% of the original miRNA
amount was still detected in 50kDa ﬁltrate (Figure 4A).
This data suggest that extracellular miRNA in blood
plasma and conditioned media is associated with a
protein of MW between 300 and 50kDa. It is well-known
that in the cell mature miRNAs are directly bound to
Ago2, a 96kDa protein responsible for the endonuclease
cleavage of targeted mRNA (1). Accordingly, anti-Ago2
monoclonal antibody has previously been shown to be
effective in capturing cellular miRNAs (19). To determine
if the extracellular miRNA is also associated with Ago2
protein, the retinates (remnants that did not pass through
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Figure 2. (A) The procedure for the fractionation of human blood plasma and conditioned media. Cell-debris free (1200g following 14000g cen-
trifugation) blood plasma diluted 12 times in PBS and MCF7 cells conditioned media were used as starting samples. Microvesicles were removed
from the samples by ﬁltration through 0.22mm ﬁlters; exosome-free fractions were obtained by ultracentrifugation at 110000g. Furthermore, frac-
tionation of 0.22mm ﬁltered samples was performed using 300, 100 and 50kDa MWCO nanomembranes. (B) The efﬁcacy of ultracentrifugation to
remove exosomes and large proteins from plasma was assessed by SDS–PAGE gel of the 110000g pellets. Coomassie blue (left) staining and western
immunoblot (right) had shown that the ﬁrst ultracentrifugation (PI pellet) removed large proteins (>300kDa) and exosomes (as judged by exosomal
marker protein CD9) from the plasma supernatant. While the pellet obtained after second ultracentrifugation of the same supernatant (PII) at the
same force did not contain any detectable amounts of proteins including exosomal marker. (C and D) The level of three miRNA species miR-16,
miR-21 and miR-24 was quantitatively assayed in the conditioned media (C) and blood plasma (D) samples after each fractionation step with
individual TaqMan miRNA Assays. Spiked in cel-miR-39 was used as normalization control for all samples. Data presented as relative miRNA fold
change. Each bar represents mean (SD) of three independent experiments (n=3).
Table 1. Non-miRNA species in cells and conditioned media
Non-miRNA species AvCt [cells]±SD AvCt [media]±SD
MammU6 12.9±0.7 24.6±0.5
RNU24 16.9±0.04 33.5±0.5
RNU43 23.1±0.2 Undetermined
RNU44 15.1±0.4 Undetermined
RNU48 13.2±0.4 29.0±0.4
RNU6B 24.8±0.2 Undetermined
7228 Nucleic Acids Research, 2011,Vol.39, No. 16the nanoﬁlters) collected after ultraﬁltration of serum-free
conditional media (Figure 4A) were subjected to western
immunoblot analysis with anti-Ago2 monoclonal
antibody (Figure 4B). As we expected, Ago2 speciﬁc
bands were observed in both 100 and 50kDa retinates,
while no Ago2 was detected in 300kDa retinates. The
relative intensities of Ago2 bands on the western blot cor-
responded to the amounts of miRNAs depleted from the
ﬁltrates (Figure 4A). More importantly, the amount of
Ago2 in MCF7 conditioned media and in MCF7 cell
lysates was proportional to their miRNAs content that
was estimated by visual comparison of Ago2 signals on
western blot and normalized Ct values of miR-16 and
miR-24 (Figure 4C). To further conﬁrm the binding of
extracellular miRNAs to Ago2 protein in blood plasma
and conditioned media, anti-Ago2 and control
immunoprecipitates were subjected to TaqMan miRNA
Assays (Figure 4D and E). In consistency with the
western blot data, miRNAs were detected in anti-Ago2
immunoprecipitates while control immunoprecipitates
(containing no anti-Ago2) were almost totally free of
miRNAs. Moreover, incubation of both blood plasma
and cells media with anti-Ago2 antibody caused the de-
pletion of miRNA from the samples. Ultraﬁltration and
immunoprecipitation experiments were performed in a
detergent-free environment, therefore, targeting a native
form of extracellular miRNA/Ago2. Figure 4D and E
included only the co-immunoprecipitation performed
when 5mg of anti-Ago2 was used (when the maximal
recovery of miRNAs was observed). Further increase of
the anti-Ago2 antibody per reaction (from 5 to 10mg) did
not signiﬁcantly increase miRNA content in the pellet.
The second immunoprecipitation with anti-Ago2 yielded
signiﬁcantly smaller amount of miRNA as compared to
ﬁrst immunoprecipitation (data not shown). The remain-
ing miRNA in the supernatant is, therefore, unlikely to be
attributed to larger parts to the efﬁciency of
co-immunoprecipitation but could be associated with
other Ago proteins, speciﬁcally Ago1, Ago3 and Ago4.
Unfortunately, there are no well described antibodies
against Ago1, Ago3 and Ago4 for the immunopre-
cipitation available. To test the hypothesis that other
Ago proteins loaded with miRNA can also be present in
the extracellular environment we have tested the ability of
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Figure 3. miRNA spectra of the supernatants and the pellets obtained after ultracentrifugation of MCF7 cells conditioned media (A) and human
blood plasma (B) as measured by TaqMan miRNA Low Density arrays (Applied Biosystems). Blood plasma (1ml) was combined with 11ml of
1PBS before ultracentrifugation. ‘Left’: Correlation plots shows Ct values of miRNA signals obtained from total RNA extracted from 400ml (1/30
volume) of supernatants and total pellets (pellets were obtained after ultracentrifugation of total 12ml of samples). Note that only 1/30 of total
supernatants were taken for the RNA isolation and subsequently for the TaqMan Low Density Arrays. MiRNAs which were undetected on the
array (Ct>35) were assigned Ct values of 40. ES—miRNAs presented exclusively in the supernatant; EP—miRNAs presented exclusively in the
pellets (exclusively detected miRNAs are listed in Supplementary Data). ‘Right’: Those miRNAs that were detected in both supernatants and pellets
demonstrated a dramatic difference in the content. Note: amount of miRNAs in the pellets is much lower than in supernatants.
Nucleic Acids Research, 2011,Vol.39, No. 16 7229anti-FLAG antibody to precipitate miRNAs from 3-days
conditional media of cells transfected with constructs
encoding FLAG-fused human Ago1, Ago2, Ago3 and
Ago4 (Figure 4F). The highest amount of miRNA in the
media was still associated with Ago2; however, the media
of the cells transfected with Ago1 also contained signiﬁ-
cant amounts of miRNA. It is therefore, feasible that
the remaining miRNA in the blood plasma and condi-
tioned media can be bound to other members of the
Ago family.
In one recent report it was hypothesized that miRNA in
serum-free conditioned media can be bound to nucleo-
phosmin (NPM1) (13). This assumption was based on
the fact that NPM1 was able to protect miRNA from
RNAses when mixed with synthetic miRNA in vitro and
was present in serum-free conditioned media in relatively
high amounts. We indeed detected high amounts of
NPM1 in 1-day conditioned serum-free media from
MCF7 cells. However, the ultraﬁltration patterns of
NPM1 and extracellular miRNA were signiﬁcantly differ-
ent (Figure 4A and B). It remains to be elucidated, why
33kDa NPM1 was found exclusively in 100kDa retinate
fraction (did not pass through 100kDa ﬁlters). However,
in the cell NPM1 forms complexes with some other
proteins (like nucleolin and ribonucleoproteins) and
undergo oligomerization (20).
miRNA remains stable for the prolonged periods after the
cell death
We have also noticed that extracellular miRNA levels in
conditioned media increased with higher rate of cell death
(data not shown). This observation was the basis for our
hypothesis that extracellular miRNAs might be
by-products of dead cells that persist in the extracellular
space due to their unusual stability. We further evaluated
the stability of the intracellular miRNAs in the lysates of
MCF-7 cells. For that reason, 510
6 MCF7 cells were
lysed in 1ml of buffer containing mild detergent (1%
NP-40) and no protease or phosphatase inhibitors. The
lysate was then diluted 10 times with PBS to reduce the
concentration of the detergent, passed through 0.22mm
ﬁlters and split in two parts. One part of the lysate was
immediately frozen and the other part was stored at room
temperature. Two months later, total RNA was isolated
from both lysates. Species of hsa-miR-16, hsa-miR-21 and
hsa-miR-24 were analyzed by TaqMan miRNA qRT–
PCR (Figure 5A). To our surprise, both the levels of
miRNAs and the amount of Ago2 protein in two lysates
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conditioned media from MCF7 cells was fractionated using nanomembrane concentrators of 300, 100 and 50kDa MWCO. (A) Individual TaqMan
miRNA assays were used to quantify the species of miR-16, miR-21 and miR-24 which remained in the solution after each ultraﬁltration step.
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lysate was diluted so that the miRNA content in it equaled approximately the miRNA content in the concentrated serum-free media. Finally, western
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value 1), each bar represents mean (SD) of three independent experiments. Cel-miR-39 spiked in during RNA isolation step was used as normal-
ization control. Note, the anti-Ago2 antibody induced a depletion of the miRNAs from conditioned media and blood plasma. (F) The levels of
miR-16, miR-21 and miR-24 were measured in the anti-FLAG pellets obtained from HEK293T cells conditioned medias 72h after transfection with
plasmids-encoding FLAG-Ago1, FLAG-Ago2, FLAG-Ago3, FLAG-Ago4 or empty vector (K).
7230 Nucleic Acids Research, 2011,Vol.39, No. 16were not signiﬁcantly different. On the contrary, no
miRNA or Ago2 have been detected in conditioned
serum-free media from MCF7 cells which was stored for
2 months at RT (Figure 5B). The sensitivity of both
miRNA and Ago2 to the overtime degradation in
serum-free media can be explained by the fact that it
contains signiﬁcantly less contaminating proteins as
compared to serum-containing conditioned media, blood
plasma or cell lysate. It is known that miRNA process-
ing machinery in the cell leads to the production of
mature miRNA strand attached to one of the Ago
proteins and so far there were no indications that intra-
cellular mature miRNAs can be directly associated with
other proteins. Given a remarkable stability of miRNA/
Ago2 complexes it can be logically anticipated that
miRNA are found in signiﬁcant amounts in human
body ﬂuids.
The fact that intracellular miRNAs can be preserved
in the extracellular milieu for at least 2 months after
cell lysis, supports our hypothesis that extracellular
miRNAs probably originate as by-products from dead
cells and remain stable for prolonged time in the extracel-
lular space due to the high stability of Ago2/miRNA
complex. Accordingly, non-miRNA species such as U6
RNA, RNU24, RNU43, RNU44, RNU48, RNU6B and
mRNAs which are not associated with Ago proteins are
either totally absent in the extracellular environment or
detected in dramatically lower amounts (as compared to
intracellular) (Figure 1A and Table1).
DISCUSSION
In this work, we addressed questions regarding stability,
origin and possible biological function of circulating
extracellular miRNA in human peripheral blood and cell
culture media. As a major tool for the detection of mature
miRNAs, we utilized individual TaqMan miRNA assays
for three common miRNAs (hsa-miR-16, hsa-miR-21 and
hsa-miR-24). These miRNAs were all readily detected in
human blood plasma and conditioned media of several
cancer cell lines. However, all three miRNAs were
present in signiﬁcantly higher levels in the cells mono-
layers compared to 3-day conditioned media.
Furthermore, array analysis showed that intracellular
and extracellular miRNA content was well correlated for
most of the miRNAs. However, also some speciﬁc—espe-
cially intracellular speciﬁc—miRNAs were detected.
Generally, miRNAs were present in much lower concen-
trations in conditioned media than in cell monolayers.
Nevertheless, some miRNAs were found exclusively in
the media but only in trace amounts (Ct ranging from
32.6 to 33.8). A number of recent studies demonstrating
that exosomes derived from several cell lines contain
miRNAs forced us to test the hypothesis of exosomes-
mediated nuclease protection of extracellular miRNA
(12,14–16). However, quantiﬁcation of three individual
miRNAs in different fractions obtained after ultraﬁltra-
tion and ultracentrifugation of blood plasma and cells
media revealed that >97% of these miRNA amounts are
exosome free. Furthermore, array analysis of miRNA dis-
tribution in the supernatants and pellets obtained after
ultracentrifugation revealed that only small amounts of
miRNAs were associated with pellets (exosomes)
fractions.
Previously, Wang et al. (13) reported a phenomenon of
active miRNAs export from cells after serum deprivation.
In accordance with our data, they also observed that sig-
niﬁcant fraction of extracellular miRNA were not
associated with cell-derived vesicles. The authors,
however, suggested the existence of a speciﬁc mechanism
of miRNA transportation outside the cells and that the
extracellular miRNA was associated with 33kDa RNA
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Figure 5. Stability of miRNA and Ago2. (A) MCF7 cells were lysed in a buffer containing no protease or phosphatase inhibitors and either
frozen or left at room temperature for 2 months. (B) Serum-free conditioned media obtained after incubation with MCF7 cells monolayer
for 24h was either frozen or left at RT for 2 months. The species of miRNAs and Ago2 content were analyzed by TaqMan miRNA qRT–PCR
assays and western immunoblot, respectively, in both lysates and conditioned medias. Data presented as a fold change at 2 month point versus 0
point (frozen samples), each bar represents mean (SD) of three independent RNA isolations (n=3). Cel-miR-39 was used as normalization control.
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however, suggest that extracellular miRNAs are bound
to 96kDa Ago proteins and Ago2 in particular. These
are the same proteins with which miRNAs are naturally
associated within the cell as being a part of RNA-induced
silencing complex (1,19). Ago2/miRNAs complexes are
highly nuclease/protease resistant as we had shown that
miRNA remained stable in the cell lysates for at least 2
months. The unusual stability of the intracellular miRNA
provides a ﬁrm grounding for the proposition that the
large portion of extracellular miRNA might be
by-products of dead cells. According to our hypothesis,
the miRNA/Ago2 complexes are released from the cells
upon necrosis or apoptosis. Unlike other RNA species,
miRNA remains stable in the extracellular space for
long periods due to the signiﬁcant resistance of Ago2 exo-
nuclease to degradation. Further our array analyses point
to the direction that some miRNA/Ago2 complexes might
be directly released by cells. It remains to be shown if and
to what extent miRNA/Ago complexes can be released
from cells in a directed manner in order to fulﬁll a para-
crine function. Nevertheless, our results are in agreement
with the observation that some miRNAs detected in
plasma or conditioned media can indeed be associated
with exosomes. Thus, TaqMan Low Density Array
analysis of 110000g pellets and supernatants of both
blood plasma and conditioned media revealed the
presence of several pellet-speciﬁc miRNAs (however,
these miRNA had Ct>30.7). Furthermore, when
studying exosome-speciﬁc miRNAs investigators have to
take into account the possible contamination of exosome
fractions with Ago2 loaded miRNAs.
Recently, it has been suggested that extracellular
miRNA entrapped in exosomes to be involved in intercel-
lular communication (12,14,15). Our data, however, show
that only a small minority of extracellular miRNA can be
associated with exosomes. It has to be shown, if Ago/
miRNA complexes can be released from cells and
mediate cell–cell communication. It is questionable
whether the extracellular miRNAs associated with
exosomes are present outside the cells in physiologically
relevant concentrations (necessary to induce functional
impact in other cells). However, a paradigm of autocrine
and paracrine miRNA signaling through exosomes cannot
be excluded.
Within recent years, there has been an enormous
interest in investigating circulating miRNAs in blood
plasma/serum as potential biomarkers for early cancer
diagnoses. The detection of cancer-speciﬁc miRNAs in
the blood plasma/serum of cancer patients has been
shown in multiple reports (4,8,16). Our study is in agree-
ment with and strongly supports the possibility of using
miRNAs for cancer diagnosis since cancer-speciﬁc
Ago2-associated miRNAs should remain in the blood in
stable form as any other miRNAs. One has to be aware,
however, that most of peripheral plasma miRNA are
likely to derive from blood cells, liver, lungs, kidney and
other organs where extensive contact between cells and the
blood plasma occurs. Therefore, cancer-speciﬁc miRNAs
can be masked by miRNAs from other sources. However,
it could be anticipated that the level of cancer-speciﬁc
miRNAs to be increased in the blood plasma. In a
similar way, increase in particular ‘tissue speciﬁc’ or
‘organ speciﬁc’ miRNAs in blood plasma (or other body
ﬂuids) could serve as an indication of toxicity of a particu-
lar tissue/organ (10,11).
The recent discovery of virally encoded miRNAs in
several pathogenic human viruses suggests that miRNAs
may function in interspecies regulation involving viral
miRNAs and host genes (21,22). It is thus conceivable
that circulating viral miRNAs might be exploited for the
diagnostics of viral infections since viral miRNA should
be preserved in the extracellular space after the infected
host cells die. More importantly viral miRNAs are differ-
ent from host miRNAs, and therefore can serve as a
speciﬁc marker for the diagnosis, especially for those
viruses for which antibody-based detection systems are
not yet established. Finally, we hypothesize that extracel-
lular miRNAs may contribute to the investigation of
miRNAs—regulators of cell death. If Ago2-associated
miRNAs releases after the cells die, the proﬁles of extra-
cellular miRNAs should represent the miRNA proﬁle of
the cells in the very late stage of apoptosis. Therefore,
quantitative comparison of miRNA signatures in given
cells and the media could contribute to the identiﬁcation
of miRNA circuit involved in apoptosis.
Our ﬁndings also suggest that restricting the analysis
of biomarkers to only exosomal miRNA ignores vast
majority of the circulating miRNAs in blood plasma.
Moreover, our data shed light on the problem of normal-
ization of miRNA expression applying non-miRNA
species (like U6, etc.) due to their divergent stability
of circulating miRNA. Further, between miRNAs
themselves normalization can be difﬁcult if miRNAs are
originating from different extracellular traveling systems
(ago-bound versus exosomal) as here—and maybe even
between different ago-carriers—the stability of miRNAs
can be different. The best way to overcome these problems
is the implementation of exactly the same standardized
processing protocols of samples of different comparison
groups and within study cohorts.
To summarize, in this study, we have shown that the
overwhelming majority of the nuclease-resistant extracel-
lular miRNA in plasma and cell culture media is ﬂoating
outside exosomes and is bound to Ago2 protein—a part of
the RNA-induced silencing complex. We also found indi-
cations that extracellular miRNA can be bound to other
Ago proteins (especially Ago1). It is likely that large parts
of extracellular circulating miRNAs are by-products of
dead or dying cells that persist due to the high stability
of the miRNA/Ago 2 complex. Whether and to what
extent miRNA/Ago complexes can speciﬁcally be
released from cells and function in a paracrine manner
needs to be investigated.
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